Original Source(s)
Related Content
FDA Names PreCheck Participants
Seven companies will participate in a two-phase program that provides early FDA technical guidance during development of new US pharmaceutical manufacturing facilities.
June 30, 2026
-
3 min
Can Proteomics Refine Lung Screening?
Proteomic biomarkers improve short-term lung cancer risk assessment.
June 1, 2026
-
5 min
FDA Expands Marstacimab Indication in Hemophilia A and B
Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.
June 8, 2026
-
3 min